BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30877405)

  • 21. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
    Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
    J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population.
    Dingemans SA; de Rooij PD; van der Vuurst de Vries RM; Budel LM; Contant CM; van der Pool AE
    Ann Surg Oncol; 2016 Feb; 23(2):477-81. PubMed ID: 26369528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.
    Tvedskov TF; Jensen MB; Balslev E; Garne JP; Vejborg I; Christiansen P; Ejlertsen B; Kroman N
    Acta Oncol; 2016; 55(4):455-9. PubMed ID: 26452696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a technique using microbubbles and contrast enhanced ultrasound (CEUS) to biopsy sentinel lymph nodes (SLN) in pre-operative breast cancer patients with a normal grey-scale axillary ultrasound.
    Cox K; Sever A; Jones S; Weeks J; Mills P; Devalia H; Fish D; Jones P
    Eur J Surg Oncol; 2013 Jul; 39(7):760-5. PubMed ID: 23632319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
    Guenther JM; Hansen NM; DiFronzo LA; Giuliano AE; Collins JC; Grube BL; O'Connell TX
    Arch Surg; 2003 Jan; 138(1):52-6. PubMed ID: 12511150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma.
    Hanna MG; Jaffer S; Bleiweiss IJ; Nayak A
    Mod Pathol; 2014 Nov; 27(11):1489-98. PubMed ID: 24743214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Głowacka-Mrotek I; Sowa M; Biedka M; Kołacińska A
    Breast J; 2018 Sep; 24(5):724-729. PubMed ID: 29476570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis.
    Sasada S; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
    Breast Cancer; 2021 Sep; 28(5):1016-1022. PubMed ID: 33740208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node.
    Tvedskov TF; Jensen MB; Lisse IM; Ejlertsen B; Balslev E; Kroman N
    Int J Cancer; 2012 Nov; 131(10):2367-75. PubMed ID: 22344558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of sentinel lymph nodes in patients with breast cancer using one-step nucleic acid amplification (OSNA): Does not lead to overtreatment in the current era of de-escalating axillary management.
    Hintzen KFH; de Rooij L; Schouten N; van Bastelaar J; Cörvers SAJ; Janssen A; van Haaren ERM; Vissers YLJ
    Surg Oncol; 2020 Dec; 35():224-228. PubMed ID: 32932218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
    Tvedskov TF; Jensen MB; Balslev E; Kroman N
    Acta Oncol; 2014 Feb; 53(2):209-15. PubMed ID: 23772767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
    Krauth JS; Charitansky H; Isaac S; Bobin JY
    Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple Step-section Frozen Section sentinel lymph node biopsy--a review of 717 patients.
    Lim J; Govindarajulu S; Sahu A; Ibrahim N; Magdub S; Cawthorn S
    Breast; 2013 Oct; 22(5):639-42. PubMed ID: 23953247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
    Leikola J; Heikkilä P; von Smitten K; Leidenius M
    Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
    de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
    Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
    Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
    Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of nonsentinel lymph node metastasis in sentinel node-positive breast carcinoma.
    Kapur U; Rubinas T; Ghai R; Sinacore J; Yao K; Rajan PB
    Ann Diagn Pathol; 2007 Feb; 11(1):10-2. PubMed ID: 17240301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series.
    Orzalesi L; Casella D; Criscenti V; Gjondedaj U; Bianchi S; Vezzosi V; Nori J; Cecconi L; Meattini I; Livi L; Bernini M
    Breast Cancer; 2016 Jul; 23(4):640-8. PubMed ID: 25981971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.